Drug Profile
Ambroxol sustained release
Alternative Names: MUCOSOLVAN; NA872ETLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Teijin Pharma
- Developer Boehringer Ingelheim; Teijin Pharma
- Class Aniline compounds; Antibronchitics; Cyclohexylamines; Expectorants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cough